U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Sodium Acetate Injection
Status: Currently in Shortage
»Date first posted: 02/03/2016
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Fresenius Kabi USA, LLC (Reverified 06/04/2026)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00) Available Check wholesalers for inventory

Hikma Pharmaceuticals USA, Inc. (Reverified 06/11/2026)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01) Available Additional lots will be available. Product will be made available as it is released.
Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01) Unavailable Additional lots will be available in the July 2026 timeframe. Product will be made available as it is released. Demand increase for the drug

Hospira, Inc., a Pfizer Company (Reverified 06/09/2026)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05) Available
Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06) Limited Availability Next Delivery: August 2026; Estimated Recovery: September 2026. Shortage per Manufacturer: Manufacturing Delay. Other
Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73) Available
Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25) Available
Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26) Available
Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25) Available

Milla Pharmaceuticals (Reverified 06/15/2026)

Company Contact Information:
833-251-8463

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10) Limited Availability Estimated recovery: TBD Other
Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10) Available
Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10) Available
Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10) Available
Back to Top